Become a Pioneer in Preclinical PET/MR imaging
Thanks to the recent acquisition of the preclinical business from OncoVision, Bruker is now the first and only company offering revolutionary PET/MR products for preclinical MRI field strengths of up to 15.2 Tesla.
Trusted Preclinical MRI Combined with Revolutionary PET Performance
The new PET Insert is designed for simultaneous PET and MRI measurements on existing Bruker MRI instruments. It allows the total correlation of PET and MRI data in space and time with the full potential for the examination of multi-modal time course studies of tracer kinetics, therapeutic agent distribution, neuroscience and animal physiology. The new Inline PET is designed for sequential PET and MRI measurements on existing Bruker MRI instruments. It allows the spatial correlation of PET and MRI data to further improve nuclear molecular PET imaging by the multitude of morphological and functional insights known from MRI.
Benefit from Being One of the First Pioneers
Want to learn more about our unique PET/MR product range and how it can be incorporated into your existing research infrastructure? Contact us now to organise the visit of one of our experts to your site to look at implementation scenarios and conduct a feasibility study. For Bruker customers this site planning visit will be free of charge if requested by the end of June 2017.
Next Generation of PET Technology - Full Field Accuracy (FFA)
The revolutionary PET technology used in the Bruker PET/MR products incorporates patented high precision spatial localization of events in continuous crystals and MRI compatible SiPM based ultra-fast coincidence readout electronics. This unique combination of innovative technologies leads to fully quantitative PET results, with up to 12% sensitivity and 0,7 mm spatial resolution - across the entire FOV of 80 mm. Full Field Accuracy PET/MR products are fully compatible with Bruker MRI instruments up to 15.2 Tesla.
更多，请点击“阅读原文”